Sarilumab Beneficial for Polymyalgia Rheumatica Patients
THURSDAY, Oct. 5, 2023 (HealthDay News) — For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficaci…
Learn MoreSarilumab Beneficial for Polymyalgia Rheumatica Patients
THURSDAY, Oct. 5, 2023 (HealthDay News) — For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficaci…
Learn MoreSarcopenia Worsens Liver Transplant Outcomes for Patients With Cirrhosis
THURSDAY, Oct. 5, 2023 (HealthDay News) — Sarcopenia is associated with adverse outcomes after liver transplantation (LT) in patients with decompensated cirrhosis (DC), according to a study published online Sept. 21 in the Journal of Cachexia, Sarcop…
Learn MoreSarcopenia Worsens Liver Transplant Outcomes for Patients With Cirrhosis
THURSDAY, Oct. 5, 2023 (HealthDay News) — Sarcopenia is associated with adverse outcomes after liver transplantation (LT) in patients with decompensated cirrhosis (DC), according to a study published online Sept. 21 in the Journal of Cachexia, Sarcop…
Learn MoreEarly Metformin May Not Aid Gestational Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Early metformin initiation in women with gestational diabetes does not reduce the occurrence of the combination of a fasting glucose level ≥5.1 mmol/L at gestation weeks 32 or 38 or insulin initiation, accord…
Learn MoreEarly Metformin May Not Aid Gestational Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Early metformin initiation in women with gestational diabetes does not reduce the occurrence of the combination of a fasting glucose level ≥5.1 mmol/L at gestation weeks 32 or 38 or insulin initiation, accord…
Learn MoreTirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European Association for the Study of Diabetes Ann…
Learn MoreTirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European Association for the Study of Diabetes Ann…
Learn MoreCancer Drug Shortages Persist Across U.S.
THURSDAY, Oct. 5, 2023 (HealthDay News) — U.S. cancer centers continue to have shortages of commonly used chemotherapy drugs, a new survey shows, though the medications are not as scarce as they were last June.The National Comprehensive Cancer Networ…
Learn MoreKetamine Nasal Spray Shows Promise Against Tough-to-Treat Depression
THURSDAY, Oct. 5, 2023 (HealthDay News) — A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found.The trial, of nearly 700 people with…
Learn More